Eintrag weiter verarbeiten
Vaporization of prostates of ≥80 mL using a potassium‐titanyl‐phosphate laser: midterm‐results and comparison with prostates of
Gespeichert in:
| Zeitschriftentitel: | BJU International |
|---|---|
| Personen und Körperschaften: | , , , , , , , , |
| In: | BJU International, 102, 2008, 3, S. 322-327 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Wiley
|
| Schlagwörter: |
| author_facet |
Pfitzenmaier, Jesco Gilfrich, Christian Pritsch, Maria Herrmann, Daniela Buse, Stephan Haferkamp, Axel Djakovic, Nenad Pahernik, Sascha Hohenfellner, Markus Pfitzenmaier, Jesco Gilfrich, Christian Pritsch, Maria Herrmann, Daniela Buse, Stephan Haferkamp, Axel Djakovic, Nenad Pahernik, Sascha Hohenfellner, Markus |
|---|---|
| author |
Pfitzenmaier, Jesco Gilfrich, Christian Pritsch, Maria Herrmann, Daniela Buse, Stephan Haferkamp, Axel Djakovic, Nenad Pahernik, Sascha Hohenfellner, Markus |
| spellingShingle |
Pfitzenmaier, Jesco Gilfrich, Christian Pritsch, Maria Herrmann, Daniela Buse, Stephan Haferkamp, Axel Djakovic, Nenad Pahernik, Sascha Hohenfellner, Markus BJU International Vaporization of prostates of ≥80 mL using a potassium‐titanyl‐phosphate laser: midterm‐results and comparison with prostates of Urology |
| author_sort |
pfitzenmaier, jesco |
| spelling |
Pfitzenmaier, Jesco Gilfrich, Christian Pritsch, Maria Herrmann, Daniela Buse, Stephan Haferkamp, Axel Djakovic, Nenad Pahernik, Sascha Hohenfellner, Markus 1464-4096 1464-410X Wiley Urology http://dx.doi.org/10.1111/j.1464-410x.2008.07563.x <jats:sec><jats:title>OBJECTIVE</jats:title><jats:p>To compare the safety and outcome of potassium‐titanyl‐phosphate (KTP) Greenlight<jats:sup>TM</jats:sup> (Laserscope, AMS, Minnetonka, MN, USA) vaporization for treating benign prostatic hyperplasia (BPH) in prostates of ≥80 vs <80 mL.</jats:p></jats:sec><jats:sec><jats:title>PATIENTS AND METHODS</jats:title><jats:p>In all, 204 consecutive patients were enrolled into this prospective study; 31 were excluded from analysis for various reasons, thus 173 (median age 66.8 years; 39 with prostates of ≥80 mL) were evaluated for maximum urinary flow rate (Q<jats:sub>max</jats:sub>), postvoid residual urine (PVR), the International Prostate Symptom Score (IPSS), and quality‐of‐life (QoL) score. The median follow‐up was 11.7 months. Of the 173 men, 26.6% were anaesthesiological high‐risk patients and 32.4% took anticoagulants.</jats:p></jats:sec><jats:sec><jats:title>RESULTS</jats:title><jats:p>The Q<jats:sub>max</jats:sub> improved in prostates of ≥80 mL from 6.9 mL/s before to 15.3 mL/s immediately after catheter removal, and 23.4 mL/s after 3 months (<jats:italic>P</jats:italic> < 0.001). The improvement was similar to that in smaller prostates. There were equally effective changes in PVR (<jats:italic>P</jats:italic> < 0.001). The IPSS decreased from 19.0 before to 7.0, 4.0 and 5.5 at 3, 6 and 12 months after surgery (<jats:italic>P</jats:italic> < 0.001). Changes did not differ from those in smaller glands. The results were similar for QoL (<jats:italic>P</jats:italic> < 0.001). During surgery there was no major bleeding and no transurethral resection syndrome. There was acute urinary retention after catheter removal in 10.4% of men; 4.6% developed urinary tract infections, whereas the rate was higher in men with larger prostates (10.3%). The re‐operation rate was higher in men with larger prostates, at 23.1% vs 10.4% (<jats:italic>P</jats:italic> = 0.09).</jats:p></jats:sec><jats:sec><jats:title>CONCLUSION</jats:title><jats:p>KTP laser vaporization is a safe and effective procedure for surgically treating BPH. The functional outcome in larger prostates is similar to that in smaller glands, but there was a serious trend to a higher re‐operation rate in men with larger prostates.</jats:p></jats:sec> Vaporization of prostates of ≥80 mL using a potassium‐titanyl‐phosphate laser: midterm‐results and comparison with prostates of <80 mL BJU International |
| doi_str_mv |
10.1111/j.1464-410x.2008.07563.x |
| facet_avail |
Online |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjE0NjQtNDEweC4yMDA4LjA3NTYzLng |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjE0NjQtNDEweC4yMDA4LjA3NTYzLng |
| institution |
DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-D161 |
| imprint |
Wiley, 2008 |
| imprint_str_mv |
Wiley, 2008 |
| issn |
1464-4096 1464-410X |
| issn_str_mv |
1464-4096 1464-410X |
| language |
English |
| mega_collection |
Wiley (CrossRef) |
| match_str |
pfitzenmaier2008vaporizationofprostatesof80mlusingapotassiumtitanylphosphatelasermidtermresultsandcomparisonwithprostatesof |
| publishDateSort |
2008 |
| publisher |
Wiley |
| recordtype |
ai |
| record_format |
ai |
| series |
BJU International |
| source_id |
49 |
| title |
Vaporization of prostates of ≥80 mL using a potassium‐titanyl‐phosphate laser: midterm‐results and comparison with prostates of |
| title_unstemmed |
Vaporization of prostates of ≥80 mL using a potassium‐titanyl‐phosphate laser: midterm‐results and comparison with prostates of |
| title_full |
Vaporization of prostates of ≥80 mL using a potassium‐titanyl‐phosphate laser: midterm‐results and comparison with prostates of |
| title_fullStr |
Vaporization of prostates of ≥80 mL using a potassium‐titanyl‐phosphate laser: midterm‐results and comparison with prostates of |
| title_full_unstemmed |
Vaporization of prostates of ≥80 mL using a potassium‐titanyl‐phosphate laser: midterm‐results and comparison with prostates of |
| title_short |
Vaporization of prostates of ≥80 mL using a potassium‐titanyl‐phosphate laser: midterm‐results and comparison with prostates of |
| title_sort |
vaporization of prostates of ≥80 ml using a potassium‐titanyl‐phosphate laser: midterm‐results and comparison with prostates of <80 ml |
| topic |
Urology |
| url |
http://dx.doi.org/10.1111/j.1464-410x.2008.07563.x |
| publishDate |
2008 |
| physical |
322-327 |
| description |
<jats:sec><jats:title>OBJECTIVE</jats:title><jats:p>To compare the safety and outcome of potassium‐titanyl‐phosphate (KTP) Greenlight<jats:sup>TM</jats:sup> (Laserscope, AMS, Minnetonka, MN, USA) vaporization for treating benign prostatic hyperplasia (BPH) in prostates of ≥80 vs <80 mL.</jats:p></jats:sec><jats:sec><jats:title>PATIENTS AND METHODS</jats:title><jats:p>In all, 204 consecutive patients were enrolled into this prospective study; 31 were excluded from analysis for various reasons, thus 173 (median age 66.8 years; 39 with prostates of ≥80 mL) were evaluated for maximum urinary flow rate (Q<jats:sub>max</jats:sub>), postvoid residual urine (PVR), the International Prostate Symptom Score (IPSS), and quality‐of‐life (QoL) score. The median follow‐up was 11.7 months. Of the 173 men, 26.6% were anaesthesiological high‐risk patients and 32.4% took anticoagulants.</jats:p></jats:sec><jats:sec><jats:title>RESULTS</jats:title><jats:p>The Q<jats:sub>max</jats:sub> improved in prostates of ≥80 mL from 6.9 mL/s before to 15.3 mL/s immediately after catheter removal, and 23.4 mL/s after 3 months (<jats:italic>P</jats:italic> < 0.001). The improvement was similar to that in smaller prostates. There were equally effective changes in PVR (<jats:italic>P</jats:italic> < 0.001). The IPSS decreased from 19.0 before to 7.0, 4.0 and 5.5 at 3, 6 and 12 months after surgery (<jats:italic>P</jats:italic> < 0.001). Changes did not differ from those in smaller glands. The results were similar for QoL (<jats:italic>P</jats:italic> < 0.001). During surgery there was no major bleeding and no transurethral resection syndrome. There was acute urinary retention after catheter removal in 10.4% of men; 4.6% developed urinary tract infections, whereas the rate was higher in men with larger prostates (10.3%). The re‐operation rate was higher in men with larger prostates, at 23.1% vs 10.4% (<jats:italic>P</jats:italic> = 0.09).</jats:p></jats:sec><jats:sec><jats:title>CONCLUSION</jats:title><jats:p>KTP laser vaporization is a safe and effective procedure for surgically treating BPH. The functional outcome in larger prostates is similar to that in smaller glands, but there was a serious trend to a higher re‐operation rate in men with larger prostates.</jats:p></jats:sec> |
| container_issue |
3 |
| container_start_page |
322 |
| container_title |
BJU International |
| container_volume |
102 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792344620941705217 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T17:10:30.174Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Vaporization+of+prostates+of+%E2%89%A580%E2%80%83mL+using+a+potassium%E2%80%90titanyl%E2%80%90phosphate+laser%3A+midterm%E2%80%90results+and+comparison+with+prostates+of+&rft.date=2008-08-01&genre=article&issn=1464-410X&volume=102&issue=3&spage=322&epage=327&pages=322-327&jtitle=BJU+International&atitle=Vaporization+of+prostates+of+%E2%89%A580%E2%80%83mL+using+a+potassium%E2%80%90titanyl%E2%80%90phosphate+laser%3A+midterm%E2%80%90results+and+comparison+with+prostates+of+%3C80%E2%80%83mL&aulast=Hohenfellner&aufirst=Markus&rft_id=info%3Adoi%2F10.1111%2Fj.1464-410x.2008.07563.x&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792344620941705217 |
| author | Pfitzenmaier, Jesco, Gilfrich, Christian, Pritsch, Maria, Herrmann, Daniela, Buse, Stephan, Haferkamp, Axel, Djakovic, Nenad, Pahernik, Sascha, Hohenfellner, Markus |
| author_facet | Pfitzenmaier, Jesco, Gilfrich, Christian, Pritsch, Maria, Herrmann, Daniela, Buse, Stephan, Haferkamp, Axel, Djakovic, Nenad, Pahernik, Sascha, Hohenfellner, Markus, Pfitzenmaier, Jesco, Gilfrich, Christian, Pritsch, Maria, Herrmann, Daniela, Buse, Stephan, Haferkamp, Axel, Djakovic, Nenad, Pahernik, Sascha, Hohenfellner, Markus |
| author_sort | pfitzenmaier, jesco |
| container_issue | 3 |
| container_start_page | 322 |
| container_title | BJU International |
| container_volume | 102 |
| description | <jats:sec><jats:title>OBJECTIVE</jats:title><jats:p>To compare the safety and outcome of potassium‐titanyl‐phosphate (KTP) Greenlight<jats:sup>TM</jats:sup> (Laserscope, AMS, Minnetonka, MN, USA) vaporization for treating benign prostatic hyperplasia (BPH) in prostates of ≥80 vs <80 mL.</jats:p></jats:sec><jats:sec><jats:title>PATIENTS AND METHODS</jats:title><jats:p>In all, 204 consecutive patients were enrolled into this prospective study; 31 were excluded from analysis for various reasons, thus 173 (median age 66.8 years; 39 with prostates of ≥80 mL) were evaluated for maximum urinary flow rate (Q<jats:sub>max</jats:sub>), postvoid residual urine (PVR), the International Prostate Symptom Score (IPSS), and quality‐of‐life (QoL) score. The median follow‐up was 11.7 months. Of the 173 men, 26.6% were anaesthesiological high‐risk patients and 32.4% took anticoagulants.</jats:p></jats:sec><jats:sec><jats:title>RESULTS</jats:title><jats:p>The Q<jats:sub>max</jats:sub> improved in prostates of ≥80 mL from 6.9 mL/s before to 15.3 mL/s immediately after catheter removal, and 23.4 mL/s after 3 months (<jats:italic>P</jats:italic> < 0.001). The improvement was similar to that in smaller prostates. There were equally effective changes in PVR (<jats:italic>P</jats:italic> < 0.001). The IPSS decreased from 19.0 before to 7.0, 4.0 and 5.5 at 3, 6 and 12 months after surgery (<jats:italic>P</jats:italic> < 0.001). Changes did not differ from those in smaller glands. The results were similar for QoL (<jats:italic>P</jats:italic> < 0.001). During surgery there was no major bleeding and no transurethral resection syndrome. There was acute urinary retention after catheter removal in 10.4% of men; 4.6% developed urinary tract infections, whereas the rate was higher in men with larger prostates (10.3%). The re‐operation rate was higher in men with larger prostates, at 23.1% vs 10.4% (<jats:italic>P</jats:italic> = 0.09).</jats:p></jats:sec><jats:sec><jats:title>CONCLUSION</jats:title><jats:p>KTP laser vaporization is a safe and effective procedure for surgically treating BPH. The functional outcome in larger prostates is similar to that in smaller glands, but there was a serious trend to a higher re‐operation rate in men with larger prostates.</jats:p></jats:sec> |
| doi_str_mv | 10.1111/j.1464-410x.2008.07563.x |
| facet_avail | Online |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjE0NjQtNDEweC4yMDA4LjA3NTYzLng |
| imprint | Wiley, 2008 |
| imprint_str_mv | Wiley, 2008 |
| institution | DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161 |
| issn | 1464-4096, 1464-410X |
| issn_str_mv | 1464-4096, 1464-410X |
| language | English |
| last_indexed | 2024-03-01T17:10:30.174Z |
| match_str | pfitzenmaier2008vaporizationofprostatesof80mlusingapotassiumtitanylphosphatelasermidtermresultsandcomparisonwithprostatesof |
| mega_collection | Wiley (CrossRef) |
| physical | 322-327 |
| publishDate | 2008 |
| publishDateSort | 2008 |
| publisher | Wiley |
| record_format | ai |
| recordtype | ai |
| series | BJU International |
| source_id | 49 |
| spelling | Pfitzenmaier, Jesco Gilfrich, Christian Pritsch, Maria Herrmann, Daniela Buse, Stephan Haferkamp, Axel Djakovic, Nenad Pahernik, Sascha Hohenfellner, Markus 1464-4096 1464-410X Wiley Urology http://dx.doi.org/10.1111/j.1464-410x.2008.07563.x <jats:sec><jats:title>OBJECTIVE</jats:title><jats:p>To compare the safety and outcome of potassium‐titanyl‐phosphate (KTP) Greenlight<jats:sup>TM</jats:sup> (Laserscope, AMS, Minnetonka, MN, USA) vaporization for treating benign prostatic hyperplasia (BPH) in prostates of ≥80 vs <80 mL.</jats:p></jats:sec><jats:sec><jats:title>PATIENTS AND METHODS</jats:title><jats:p>In all, 204 consecutive patients were enrolled into this prospective study; 31 were excluded from analysis for various reasons, thus 173 (median age 66.8 years; 39 with prostates of ≥80 mL) were evaluated for maximum urinary flow rate (Q<jats:sub>max</jats:sub>), postvoid residual urine (PVR), the International Prostate Symptom Score (IPSS), and quality‐of‐life (QoL) score. The median follow‐up was 11.7 months. Of the 173 men, 26.6% were anaesthesiological high‐risk patients and 32.4% took anticoagulants.</jats:p></jats:sec><jats:sec><jats:title>RESULTS</jats:title><jats:p>The Q<jats:sub>max</jats:sub> improved in prostates of ≥80 mL from 6.9 mL/s before to 15.3 mL/s immediately after catheter removal, and 23.4 mL/s after 3 months (<jats:italic>P</jats:italic> < 0.001). The improvement was similar to that in smaller prostates. There were equally effective changes in PVR (<jats:italic>P</jats:italic> < 0.001). The IPSS decreased from 19.0 before to 7.0, 4.0 and 5.5 at 3, 6 and 12 months after surgery (<jats:italic>P</jats:italic> < 0.001). Changes did not differ from those in smaller glands. The results were similar for QoL (<jats:italic>P</jats:italic> < 0.001). During surgery there was no major bleeding and no transurethral resection syndrome. There was acute urinary retention after catheter removal in 10.4% of men; 4.6% developed urinary tract infections, whereas the rate was higher in men with larger prostates (10.3%). The re‐operation rate was higher in men with larger prostates, at 23.1% vs 10.4% (<jats:italic>P</jats:italic> = 0.09).</jats:p></jats:sec><jats:sec><jats:title>CONCLUSION</jats:title><jats:p>KTP laser vaporization is a safe and effective procedure for surgically treating BPH. The functional outcome in larger prostates is similar to that in smaller glands, but there was a serious trend to a higher re‐operation rate in men with larger prostates.</jats:p></jats:sec> Vaporization of prostates of ≥80 mL using a potassium‐titanyl‐phosphate laser: midterm‐results and comparison with prostates of <80 mL BJU International |
| spellingShingle | Pfitzenmaier, Jesco, Gilfrich, Christian, Pritsch, Maria, Herrmann, Daniela, Buse, Stephan, Haferkamp, Axel, Djakovic, Nenad, Pahernik, Sascha, Hohenfellner, Markus, BJU International, Vaporization of prostates of ≥80 mL using a potassium‐titanyl‐phosphate laser: midterm‐results and comparison with prostates of , Urology |
| title | Vaporization of prostates of ≥80 mL using a potassium‐titanyl‐phosphate laser: midterm‐results and comparison with prostates of |
| title_full | Vaporization of prostates of ≥80 mL using a potassium‐titanyl‐phosphate laser: midterm‐results and comparison with prostates of |
| title_fullStr | Vaporization of prostates of ≥80 mL using a potassium‐titanyl‐phosphate laser: midterm‐results and comparison with prostates of |
| title_full_unstemmed | Vaporization of prostates of ≥80 mL using a potassium‐titanyl‐phosphate laser: midterm‐results and comparison with prostates of |
| title_short | Vaporization of prostates of ≥80 mL using a potassium‐titanyl‐phosphate laser: midterm‐results and comparison with prostates of |
| title_sort | vaporization of prostates of ≥80 ml using a potassium‐titanyl‐phosphate laser: midterm‐results and comparison with prostates of <80 ml |
| title_unstemmed | Vaporization of prostates of ≥80 mL using a potassium‐titanyl‐phosphate laser: midterm‐results and comparison with prostates of |
| topic | Urology |
| url | http://dx.doi.org/10.1111/j.1464-410x.2008.07563.x |